LSE · GROW.L
Molten Ventures Plc
£6.79-£0.06 (-0.88%)
Molten Ventures Plc’s quoted price sits in the upper half of its reported 52-week range, 5.63% below the high.
Loading market information…
LSE · BPCP.L · GBp
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 05:15 PM UTC. Cached market data; not a live quote.
One-year closing-price history · GBp. Historical prices are not a forecast.
BioPharma Credit PLC’s quoted price sits in the upper half of its reported 52-week range, 1.96% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
BioPharma Credit PLC’s forward annual dividend is £0.05 per share, paid quarterly. The forward yield is 7.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow BioPharma Credit PLC’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating as an investment trust since its founding in 2016 in Exeter, United Kingdom, BioPharma Credit PLC concentrates its investments on interest-bearing debt assets. These assets are financially backed by royalties or other revenue derived from the sales of established life sciences products.
Latest available per-share figures in GBP. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£6.79-£0.06 (-0.88%)
Molten Ventures Plc’s quoted price sits in the upper half of its reported 52-week range, 5.63% below the high.
£1.58-£0.05 (-2.95%)
Metro Bank PLC’s quoted price sits in the upper half of its reported 52-week range, 15.24% below the high.
£1.22-£0.01 (-0.8%)
Cordiant Digital Infrastructure Limited’s quoted price sits in the upper half of its reported 52-week range, 5.05% below the high.
£2.93-£0.00 (-0.13%)
Ruffer Investment Company Limited’s quoted price sits in the lower half of its reported 52-week range, 8.11% below the high.
£5.57+£0.00 (+0.04%)
The Scottish American Investment Company PLC’s quoted price sits in the upper half of its reported 52-week range, 2.58% below the high.
£1.27-£0.01 (-0.67%)
Syncona Limited’s quoted price sits in the upper half of its reported 52-week range, 3.53% below the high.
£15.42+£0.14 (+0.95%)
Neuberger Private Equity Partners Limited’s quoted price sits in the upper half of its reported 52-week range, 5.72% below the high.
£9.10-£0.05 (-0.55%)
Pollen Street Group Limited’s quoted price sits in the upper half of its reported 52-week range, 6.38% below the high.
